title: Barrier to trade or barrier to profit? Why Australia's Pharmaceutical Benefits Scheme worries U.S. drug companies.
authors.affiliation: The Australia Institute.
authors.forename: Clive
authors.initials: C
authors.lastname: Hamilton
authors.forename: Buddhima
authors.initials: B
authors.lastname: Lokuge
authors.forename: Richard
authors.initials: R
authors.lastname: Denniss
mesh_terms: D001315:Australia; D003132:Commerce / Q000458:organization & administration*; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000191:economics*; D007391:International Cooperation; D019982:Organizational Case Studies; D014481:United States